267 related articles for article (PubMed ID: 24937186)
1. Design, synthesis and biological activity of piperlongumine derivatives as selective anticancer agents.
Wu Y; Min X; Zhuang C; Li J; Yu Z; Dong G; Yao J; Wang S; Liu Y; Wu S; Zhu S; Sheng C; Wei Y; Zhang H; Zhang W; Miao Z
Eur J Med Chem; 2014 Jul; 82():545-51. PubMed ID: 24937186
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel ROS inducer by merging the fragments of piperlongumine and dicoumarol.
Xu X; Fang X; Wang J; Zhu H
Bioorg Med Chem Lett; 2017 Mar; 27(5):1325-1328. PubMed ID: 28159415
[TBL] [Abstract][Full Text] [Related]
3. Horner-Wadsworth-Emmons approach to piperlongumine analogues with potent anti-cancer activity.
Han LC; Stanley PA; Wood PJ; Sharma P; Kuruppu AI; Bradshaw TD; Moses JE
Org Biomol Chem; 2016 Aug; 14(31):7585-93. PubMed ID: 27443386
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of N-heteroaromatic ring-based analogs of piperlongumine as potent anticancer agents.
Zou Y; Yan C; Zhang H; Xu J; Zhang D; Huang Z; Zhang Y
Eur J Med Chem; 2017 Sep; 138():313-319. PubMed ID: 28686911
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor.
Fan QZ; Zhou J; Zhu YB; He LJ; Miao DD; Zhang SP; Liu XP; Zhang C
Bioorg Chem; 2020 Dec; 105():104401. PubMed ID: 33113415
[TBL] [Abstract][Full Text] [Related]
6. Novel non-trimethoxylphenyl piperlongumine derivatives selectively kill cancer cells.
Zhang Y; Ma H; Wu Y; Wu Z; Yao Z; Zhang W; Zhuang C; Miao Z
Bioorg Med Chem Lett; 2017 Jun; 27(11):2308-2312. PubMed ID: 28434764
[TBL] [Abstract][Full Text] [Related]
7. Piperlongumine derivative, CG-06, inhibits STAT3 activity by direct binding to STAT3 and regulating the reactive oxygen species in DU145 prostate carcinoma cells.
Kim YH; Yoon YJ; Lee YJ; Kim CH; Lee S; Choung DH; Han DC; Kwon BM
Bioorg Med Chem Lett; 2018 Aug; 28(14):2566-2572. PubMed ID: 29807795
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel 5,6-disubstituted pyridine-2,3-dione-3-thiosemicarbazone derivatives as potential anticancer agents.
Xie W; Xie S; Zhou Y; Tang X; Liu J; Yang W; Qiu M
Eur J Med Chem; 2014 Jun; 81():22-7. PubMed ID: 24819956
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives.
Kassab AE; Gedawy EM
Eur J Med Chem; 2013 May; 63():224-30. PubMed ID: 23501108
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of a C7-aryl piperlongumine derivative with potent antimicrotubule and mutant p53-reactivating properties.
Punganuru SR; Madala HR; Venugopal SN; Samala R; Mikelis C; Srivenugopal KS
Eur J Med Chem; 2016 Jan; 107():233-44. PubMed ID: 26599530
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anticancer activity of γ-(triazolyl ethylidene)butenolides and polyfunctional pyrrolinones.
Devender N; Ramakrishna KK; Hamidullah ; Shukla SK; Konwar R; Tripathi RP
Eur J Med Chem; 2014 Jul; 82():106-19. PubMed ID: 24880230
[TBL] [Abstract][Full Text] [Related]
13. Piperlongumine derived cyclic sulfonamides (sultams): Synthesis and in vitro exploration for therapeutic potential against HeLa cancer cell lines.
Lad NP; Kulkarni S; Sharma R; Mascarenhas M; Kulkarni MR; Pandit SS
Eur J Med Chem; 2017 Jan; 126():870-878. PubMed ID: 27987486
[TBL] [Abstract][Full Text] [Related]
14. D-ring modified novel isosteviol derivatives: design, synthesis and cytotoxic activity evaluation.
Zhang T; Lu LH; Liu H; Wang JW; Wang RX; Zhang YX; Tao JC
Bioorg Med Chem Lett; 2012 Sep; 22(18):5827-32. PubMed ID: 22901386
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of novel 2'-hydroxy group substituted 2-pyridone derivatives as anticancer agents.
Lv Z; Zhang Y; Zhang M; Chen H; Sun Z; Geng D; Niu C; Li K
Eur J Med Chem; 2013 Sep; 67():447-53. PubMed ID: 23920246
[TBL] [Abstract][Full Text] [Related]
16. In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.
Radi M; Adema AD; Daft JR; Cho JH; Hoebe EK; Alexander LE; Peters GJ; Chu CK
J Med Chem; 2007 May; 50(9):2249-53. PubMed ID: 17419604
[TBL] [Abstract][Full Text] [Related]
17. Design, Synthesis and Antiproliferative Activities of Oxidative Stress Inducers Based on 2-Styryl-3,5-dihydro-4H-imidazol-4-one Scaffold.
Omar AM; Abdelghany TM; Abdel-Bakky MS; Alahdal AM; Radwan MF; El-Araby ME
Chem Pharm Bull (Tokyo); 2018 Oct; 66(10):967-975. PubMed ID: 30047515
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of some novel substituted quinazolines as antitumor agents.
Alanazi AM; Abdel-Aziz AA; Al-Suwaidan IA; Abdel-Hamide SG; Shawer TZ; El-Azab AS
Eur J Med Chem; 2014 May; 79():446-54. PubMed ID: 24763265
[TBL] [Abstract][Full Text] [Related]
19. Exploring epidermal growth factor receptor (EGFR) inhibitor features: the role of fused dioxygenated rings on the quinazoline scaffold.
Chilin A; Conconi MT; Marzaro G; Guiotto A; Urbani L; Tonus F; Parnigotto P
J Med Chem; 2010 Feb; 53(4):1862-6. PubMed ID: 20095624
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and anticancer activity of some novel 2-phenazinamine derivatives.
Gao X; Lu Y; Fang L; Fang X; Xing Y; Gou S; Xi T
Eur J Med Chem; 2013 Nov; 69():1-9. PubMed ID: 23995213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
